Codex DNA News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.03.24	Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
26.02.24	Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results (GlobeNewswire)
03.11.23	Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA (GlobeNewswire)
28.09.23	Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS (GlobeNewswire)
29.08.23	Telesis Bio Appoints William J. Kullback Chief Financial Officer (GlobeNewswire)
03.08.23	Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023 (GlobeNewswire)
08.06.23	Telesis Bio to Present at Jefferies Healthcare Conference 2023 (GlobeNewswire)
06.06.23	Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023 (GlobeNewswire)
05.06.23	Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock (GlobeNewswire)
31.05.23	Telesis Bio Secures Financing of $28.0 Million (GlobeNewswire)
23.05.23	Telesis Bio to Present at SynBioBeta 2023 (GlobeNewswire)
22.05.23	Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit (GlobeNewswire)
18.05.23	Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit (GlobeNewswire)
15.05.23	Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023) (GlobeNewswire)
11.05.23	Telesis Bio Reports First Quarter 2023 Financial Results (GlobeNewswire)
27.04.23	Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023 (GlobeNewswire)
31.03.23	Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up (GlobeNewswire)
14.03.23	Telesis Bio präsentiert auf dem RNA Leaders Europe Kongress (GlobeNewswire)
14.03.23	Telesis Bio to Present at RNA Leaders Europe Congress (GlobeNewswire)
19.10.22	Telesis Bio und Cellibre kündigen Zusammenarbeit an, um die Entwicklung des künftigen BioXp® DBC-Instruments zu optimieren (GlobeNewswire)
19.10.22	Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument (GlobeNewswire)
12.10.22	Codex DNA kündigt Plan zur Umfirmierung in Telesis Bio an (GlobeNewswire)
12.10.22	Codex DNA Announces Plan to Change Corporate Name to Telesis Bio (GlobeNewswire)
04.10.22	Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus (GlobeNewswire)
04.10.22	Codex DNA Expands Application of Proprietary Error Correction Technology (GlobeNewswire)
26.09.22	Codex DNA präsentiert automatisierte synthetische Biologie-Workstation der nächsten Generation auf der World of Technology & Science in Utrecht, Niederlande (GlobeNewswire)
26.09.22	Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands (GlobeNewswire)
19.09.22	Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation (GlobeNewswire)
19.09.22	Codex DNA stellt automatisierte Workstation für synthetische Biologie der nächsten Generation vor (GlobeNewswire)
30.06.22	Pre-market Movers: ASPN, SCWO, HYPR, DNAY, XCUR… (RTTNews)
22.06.22	Pre-market Movers: CRDL, DNAY, AMBA, ANGH, ARR… (RTTNews)
23.03.22	Codex DNA Plunges On Wider Loss, Outlook Below Estimates (RTTNews)
23.03.22	BNR's Revenue To Grow 22% In 2022; CINC To Report BrigHtn Data In 2H, SCPH To Resubmit NDA On Apr.15 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.52	1.66 %	K V
Kuehne+Nagel Int	208.30	1.61 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Lonza Grp	538.60	1.16 %	K V
Logitech Intl	75.16	1.16 %	K V
Sika	215.50	0.00 %	K V
Swiss Life Hldg	695.20	-0.20 %	K V
Holcim	87.14	-0.27 %	K V
Swiss Re	129.70	-0.50 %	K V
Zurich Insur Gr	534.80	-0.78 %	K V

Nachrichten zu Codex DNA Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten